Paclitaxel (Athenex Pharmaceutical Division, LLC.)
Welcome to the PulseAid listing for the Paclitaxel drug offered from Athenex Pharmaceutical Division, LLC.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Athenex Pharmaceutical Division, LLC. |
| NON-PROPRIETARY NAME: | paclitaxel |
| SUBSTANCE NAME: | PACLITAXEL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-03-24 |
| END MARKETING DATE: | 0000-00-00 |
Paclitaxel HUMAN PRESCRIPTION DRUG Details:
| Item Description | Paclitaxel from Athenex Pharmaceutical Division, LLC. |
| LABELER NAME: | Athenex Pharmaceutical Division, LLC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(mg/mL) |
| START MARKETING DATE: | 2017-03-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70860-200_235721cb-397d-4e44-8299-4373cd9d2497 |
| PRODUCT NDC: | 70860-200 |
| APPLICATION NUMBER: | ANDA207326 |
Other PACLITAXEL Pharmaceutical Manufacturers / Labelers:
